Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Landon

Showing results (51-60 of 133) with videos related to

Pageof 14
Sort By:
Progress in Clinical and Biological Research|January 1, 1989
Intermediate filaments and ubiquitin: a new thread in the understanding of chronic neurodegenerative diseasesR J Mayer, J Lowe, G Lennox, et al.
Neuroscience Letters|November 22, 1988
Ubiquitin is a component of neurofibrillary tangles in a variety of neurodegenerative diseasesG Lennox, J Lowe, K Morrell, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 1, 1989
Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body diseaseG Lennox, J Lowe, K Morrell, et al.
The Journal of Biological Chemistry|April 5, 1988
Characterization and partial purification of the Drosophila Kc cell ecdysteroid receptorT M Landon, B A Sage, B J Seeler, et al.
The Journal of Pathology|June 1, 1990
Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseasesJ Lowe, H McDermott, M Landon, et al.
Proteomics|October 27, 2001
Purification of poly-ubiquitinated proteins by S5a-affinity chromatographyR Layfield, D Tooth, M Landon, et al.
The Journal of Pathology|January 1, 1992
alpha B crystallin expression in non-lenticular tissues and selective presence in ubiquitinated inclusion bodies in human diseaseJ Lowe, H McDermott, I Pike, et al.
Biochemical Society Transactions|August 1, 1992
Ubiquitin, lysosomes and neurodegenerative diseasesR J Mayer, L Laszlo, A Middleton, et al.
Biochemical Society Transactions|February 1, 1994
Is there a common intracellular bioreactor in which amyloid formation is initiated in neurodegenerative diseases?R J Mayer, M Landon, J Lowe, et al.
Lancet (London, England)|August 25, 1990
Dementia with beta-amyloid deposition: involvement of alpha B-crystallin supports two main diseasesJ Lowe, M Landon, I Pike, et al.
Pageof 14

Showing results (51-60 of 133) with videos related to

Sort By:
Pageof 14
Progress in Clinical and Biological Research|January 1, 1989
Intermediate filaments and ubiquitin: a new thread in the understanding of chronic neurodegenerative diseasesR J Mayer, J Lowe, G Lennox, et al.
Neuroscience Letters|November 22, 1988
Ubiquitin is a component of neurofibrillary tangles in a variety of neurodegenerative diseasesG Lennox, J Lowe, K Morrell, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 1, 1989
Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body diseaseG Lennox, J Lowe, K Morrell, et al.
The Journal of Biological Chemistry|April 5, 1988
Characterization and partial purification of the Drosophila Kc cell ecdysteroid receptorT M Landon, B A Sage, B J Seeler, et al.
The Journal of Pathology|June 1, 1990
Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseasesJ Lowe, H McDermott, M Landon, et al.
Proteomics|October 27, 2001
Purification of poly-ubiquitinated proteins by S5a-affinity chromatographyR Layfield, D Tooth, M Landon, et al.
The Journal of Pathology|January 1, 1992
alpha B crystallin expression in non-lenticular tissues and selective presence in ubiquitinated inclusion bodies in human diseaseJ Lowe, H McDermott, I Pike, et al.
Biochemical Society Transactions|August 1, 1992
Ubiquitin, lysosomes and neurodegenerative diseasesR J Mayer, L Laszlo, A Middleton, et al.
Biochemical Society Transactions|February 1, 1994
Is there a common intracellular bioreactor in which amyloid formation is initiated in neurodegenerative diseases?R J Mayer, M Landon, J Lowe, et al.
Lancet (London, England)|August 25, 1990
Dementia with beta-amyloid deposition: involvement of alpha B-crystallin supports two main diseasesJ Lowe, M Landon, I Pike, et al.
Pageof 14